Cancer Care Ontario | Cancer Care Ontario

12 Results

Guidelines and Advice

Multidisciplinary Cancer Conference Standards

Status: Current
ID: MCC

Jun 2006

Guidelines and Advice

The Role of Trastuzumab in Adjuvant and Neoadjuvant Therapy in Women with HER2/neu-overexpressing Breast Cancer

Status: Education and Information
ID: 1-24 Version 2
Version: 2

May 2006

Guidelines and Advice

The Role of Porfimer Sodium (PhotofrinTM) in the Palliative Treatment of Esophageal Cancer

Status: Archived
ID: CED 3

Jan 2006

Guidelines and Advice

The Role of Porfimer Sodium (PhotofrinTM) in the Ablation of High-Grade Dysplasia in Barrett's Esophagus

Status: Archived
ID: CED 2
Version: 2

Jan 2006

Guidelines and Advice

The Use of Gabapentin and Tricyclic Antidepressants in the Treatment of Neuropathic Pain in Cancer Patients

Status: Archived
ID: 13-8

Oct 2006

Guidelines and Advice

Target Wait Times for Cancer Surgery in Ontario

Status: Current
ID: GL-C50-03

Apr 2006

Guidelines and Advice

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Status: Current

Updated

Mar 2025

Guidelines and Advice

Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer

Status: Current
ID: GL 17-10 v2
Version: 2

Updated

Mar 2025

Guidelines and Advice

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

Status: Current
ID: PET 2024-1

Updated

Mar 2025

Guidelines and Advice

Effective Teaching Strategies and Methods for Cancer Patient Education

Status: Current
ID: GL 20-2
Version: 2

Updated

Apr 2025

Guidelines and Advice

Follow-up for Cervical Cancer

Status: Current
ID: 4-16
Version: 2

Updated

May 2025